A phenolic acid compound and fermented soybeans, their preparation method and application
The identification of Aspeusoy acid A, a phenolic acid compound in soybean fermented by *Aspergillus cristatus*, using high-resolution mass spectrometry and nuclear magnetic resonance (NMR) techniques has solved the problem of separating and identifying novel secondary metabolites in existing technologies. This has enabled the separation of phenolic acid compounds with antioxidant activity and the biotransformation of isoflavones in soybeans, thereby enhancing the functionality and application potential of fermented soybeans.
Patent Information
- Application Number
- CN202611369421.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-04
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are insufficient to effectively isolate and identify novel secondary metabolites from the *Aspergillus cristatus* fermentation system for soybeans, and their biological activities have not been adequately studied.
High-resolution mass spectrometry and proton nuclear magnetic resonance (HMR) combined with carbon nuclear magnetic resonance (CMR) were used to identify the phenolic acid compound Aspeusoy acid A in soybean fermented by *Aspergillus cristatus* SXHBTBU1934. The compound was isolated from soybean through specific extraction and separation steps, and its antioxidant activity was verified.
A novel phenolic acid compound, Aspeusoy acid A, was successfully isolated and identified. It exhibits significant antioxidant activity and significantly enhances the biotransformation of isoflavones and the accumulation of various bioactive metabolites in soybeans during fermentation, thereby improving the functionality and application value of fermented soybeans.
Smart Images

Figure CN123106430A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of bioengineering technology, and in particular to a phenolic acid compound, fermented soybeans, their preparation method, and their applications. Background Technology
[0002] Microorganisms play a vital role in drug development, such as in penicillin, streptomycin, avermectin, and lovastatin. *Aspergillus cristatus* (…) Eurotium cristatum *Aspergillus cristatus* is a dominant microbial strain isolated from Fu brick tea and widely used in industrial fermentation. This bacterium can utilize carbon and nitrogen sources in various substrates for growth and metabolism, producing a large number of biologically active secondary metabolites, including polyketides and alkaloids. These compounds possess various pharmacological activities such as lowering blood lipids, anti-inflammation, and anti-tumor activity. Furthermore, *Aspergillus cristatus* can efficiently produce various industrial enzymes, such as cellulase, pectinase, and glucose oxidase, which have important applications in biomass energy conversion, food processing, and paper manufacturing.
[0003] Soybeans are rich in protein, lipids, and isoflavones, making them a commonly used high-quality substrate in solid-state fermentation. Microbial fermentation of soybeans allows for the full utilization of soybean resources, increasing their isoflavone content, promoting the industrial application of isoflavones, increasing added value, and enhancing the utilization and commercial value of soybeans. The glycosylation structure of flavonoids in soybeans significantly affects their absorption, distribution, and metabolism in the body. Compared to their corresponding glycoside derivatives, genistein and daidzein have higher absorption and utilization rates and stronger biological activity. With the deepening research on soy isoflavones, their functions and application potential are increasingly attracting attention worldwide, especially in the fields of health foods and pharmaceuticals.
[0004] Currently, methods for isolating novel compounds from microbial fermentation products typically involve complex extraction, fractionation, and purification steps. Furthermore, the metabolite profiles produced by different strain-substrate combinations vary significantly, making it difficult to predict and obtain specific novel compounds using conventional methods. In particular, existing techniques for studying the secondary metabolites and their activities produced by *Aspergillus cristatus* in soybean solid-state fermentation systems remain very limited. Therefore, the isolation and extraction of various secondary metabolites obtained during soybean fermentation and their potential biological activities are of significant research value. Summary of the Invention
[0005] The purpose of this invention is to provide a phenolic acid compound, fermented soybeans, its preparation method, and its application. A new secondary metabolite of *Aspergillus cristatus* was discovered for the first time in fermented soybeans. Its structure was identified by high-resolution mass spectrometry and proton and carbon NMR spectra, and it belongs to the phenolic acid compound class. This compound has antioxidant activity.
[0006] To achieve the above-mentioned objectives, the present invention provides the following technical solution: This invention provides a phenolic acid compound (Aspeusoy acid A), the structural formula of which is as follows:
[0007] Formula 1.
[0008] This invention also provides a method for preparing a phenolic acid compound (Aspeusoy acid A), comprising the following steps: S1. Inoculate the spore suspension of *Aspergillus cristatus* SXHBTBU1934 into sterilized soybeans, ferment and culture, freeze dry, and pulverize to obtain fermented soybeans; S2. The fermented soybeans were extracted with methanol solvent under ultrasonic assistance for 25-35 min, centrifuged and filtered through a membrane, and concentrated under reduced pressure to obtain a crude extract. S3. Dissolve the crude extract in a mixed solution of dichloromethane and methanol in a volume ratio of (1~2):(1~2), and separate it using a Sephadex LH-20 gel column. Collect one fraction every 30 mL to obtain fractions 1 to 9. S4. The 7th fraction obtained in step S3 was separated by high performance liquid chromatography. The chromatographic column was a ZORBAX SB-C18 with a particle size of 5 μm and a specification of 9.4 × 250 mm. The mobile phase gradient elution system was 5%~25% acetonitrile, and the receiving retention time was 23.77 minutes to obtain the compound.
[0009] Preferably, in step S1, the ratio of the spore suspension of *Aspergillus cristatus* SXHBTBU1934 to soybeans is 2-4 mL: 100 g.
[0010] Preferably, the sterilized soybeans in step S1 also contain water, and the mass-to-volume ratio of the soybeans to the water is 8~12 g: 4~8 mL.
[0011] Preferably, in step S1, the culture temperature for preparing the *Aspergillus cristatus* SXHBTBU1934 spore suspension is 28℃~35℃, the culture time is 7~10 days, and the culture medium is malt extract agar.
[0012] Preferably, the bacterial concentration of the spore suspension in step S1 is 1×10⁻⁶. 7 ~1×10 9 CFU / mL, and the accession number of the *Eurotium cristatum* SXHBTBU1934 is CGMCC NO. 21026.
[0013] Preferably, the fermentation temperature in step S1 is 28 ℃~35 ℃, and the time is 13~17 days.
[0014] Preferably, the freeze-drying temperature in step S1 is -85 ℃ to -70 ℃, and the time is 20 to 28 h.
[0015] Preferably, the ultrasonic extraction power in step S2 is 400~600 W and the frequency is 40~90kHz.
[0016] The present invention also provides a fermented soybean containing phenolic acid compounds.
[0017] Preferably, the fermented soybeans are obtained by inoculating sterilized soybeans with a spore suspension of *Aspergillus cristatus* SXHBTBU1934, fermenting, freeze-drying, and pulverizing.
[0018] The present invention also provides the application of phenolic acid compounds or fermented soybeans containing phenolic acid compounds in the preparation of functional preparations with antioxidant activity.
[0019] Compared with the prior art, the present invention has the following beneficial effects: This invention marks the first time a novel phenolic acid derivative has been isolated and identified from a specific solid-state fermentation system of soybeans fermented by *Aspergillus cristatus* SXHBTBU1934. The structure of the compound was identified through comprehensive analysis using high-resolution mass spectrometry combined with proton and carbon NMR spectroscopy, and it was named Aspeusoy acid A. This compound contains characteristic groups such as a 1,2,3-trisubstituted benzene ring, a terminal double bond, and three carboxyl signal groups. While similar to, it also exhibits significant differences from, typical phenolic acid structures, representing a completely new compound never before reported in the prior art. This provides a novel structural type for the study of microbial secondary metabolites.
[0020] The phenolic acid compound (Aspeusoy acid A) provided by this invention has antioxidant activity and an IC50 scavenging capacity for DPPH free radicals. 50 The IC50 for scavenging ABTS free radicals was 25.49 μg / mL. 50 It was 34.17 μg / mL.
[0021] The method for preparing fermented soybeans using *Aspecus cristatum* SXHBTBU1934 provided by this invention not only yields a new compound with antioxidant activity but also simultaneously promotes the biotransformation of isoflavones in soybeans and the accumulation of various fungal secondary metabolites with antioxidant, hypoglycemic, and hypolipidemic activities. After fermentation, the total isoflavone content in the soybeans increased by 15.57% compared to the raw material, and the total content of fungal secondary metabolites also reached 1.290%. It is evident that the fermented soybeans obtained by this invention not only exhibit biotransformation and increased isoflavone content but are also rich in various fungal secondary metabolites with antioxidant, hypoglycemic, and hypolipidemic activities. Furthermore, a new compound with antioxidant activity (Aspeusoy acid A) is generated, which has broad application prospects in health foods, pharmaceuticals, or functional additives. Attached Figure Description
[0022] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on the provided drawings without creative effort.
[0023] Figure 1 High-resolution mass spectrometry of the compound; Figure 2 The 1H NMR spectrum of the compound; Figure 3 The carbon NMR spectrum of the compound; Figure 4 The image shows the liquid chromatograms of fermented soybeans and raw soybeans, including: 1. daidzein, 2. daidzein, 3. genistein, 4. malonyl daidzein, 5. acetyl daidzein, 6. malonyl genistein, 7. daidzeinogen, 8. daidzein, 9. acetyl genistein, 10. genistein, and 11. a new compound, aspeusoyic acid A. Detailed Implementation
[0024] This invention provides a method for preparing the phenolic acid compound Aspeusoy acid A, comprising the following steps: S1. Inoculate the spore suspension of *Aspergillus cristatus* SXHBTBU1934 into sterilized soybeans, ferment and culture, freeze dry, and pulverize to obtain fermented soybeans; S2. The fermented soybeans were extracted with methanol solvent under ultrasonic assistance for 25-35 minutes, then centrifuged and filtered through a membrane, and concentrated under reduced pressure to obtain a crude extract. S3. Dissolve the crude extract in a mixed solution of dichloromethane and methanol in a volume ratio of 1~2:1~2, and separate it using a Sephadex LH-20 gel column. Collect one fraction every 30 mL to obtain fractions 1 to 9. S4. The 7th fraction obtained in step S3 was separated by high performance liquid chromatography. The chromatographic column was a ZORBAX SB-C18 with a particle size of 5 μm and a specification of 9.4 × 250 mm. The mobile phase gradient elution system was 5%~25% acetonitrile, and the receiving retention time was 23.77 minutes to obtain the compound.
[0025] In this invention, the ratio of the spore suspension of *Aspergillus cristatus* SXHBTBU1934 to soybeans in step S1 is 2-4 mL:100 g, preferably 2.5-3.5 mL:100 g, and more preferably 3 mL:100 g.
[0026] In this invention, the sterilized soybeans in step S1 also contain water, and the mass-to-volume ratio of the soybeans to the water is 8~12g:4~8mL; preferably 9~11g:5~7mL; and more preferably 10g:5.5mL.
[0027] In this invention, the soybeans in step S1 are also pulverized, and the preferred particle size of the pulverized soybeans is ≤2cm.
[0028] In this invention, the bacterial concentration of the spore suspension in step S1 is 1×10⁻⁶. 7 ~1×10 9 CFU / mL; preferably 1×10⁻⁶ 8 CFU / mL.
[0029] In this invention, the accession number of *Aspergillus cristatus* SXHBTBU1934 is CGMCC NO. 21026, which is the same strain used by the inventor in the prior patent application ZL 202211156412.5.
[0030] In this invention, the fermentation culture temperature in step S1 is 28 ℃~35 ℃, and the time is 13~17 days. Preferably, the culture temperature is 30 ℃~33 ℃, and the time is 14~16 days. More preferably, the culture temperature is 31 ℃, and the time is 15 days.
[0031] In this invention, the freeze-drying temperature in step S1 is -85 ℃ to -70 ℃, and the time is 20 to 28 h; preferably, the temperature is -82 ℃ to -75 ℃, and the time is 22 to 26 h; more preferably, the temperature is -80 ℃, and the time is 24 h.
[0032] In this invention, the ultrasonic extraction power in step S2 is 400~600 W, preferably 500 W; the ultrasonic frequency is 40~90 kHz, preferably 60~90 kHz, and more preferably 80 kHz; the ultrasonic time is 25~35 min, preferably 30 min.
[0033] In this invention, the crude extract in step S3 preferably uses a dichloromethane:methanol volume ratio of 1:1.
[0034] The technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the scope of protection of the present invention.
[0035] Example 1
[0036] The preparation steps for a phenolic acid compound (Aspeusoy acid A) are as follows: (1) Sterilization of raw materials: Weigh 10 g of soybeans into an Erlenmeyer flask, add 5.5 mL of distilled water, sterilize at 121℃ for 15 minutes to obtain sterilized soybeans; (2) Fermentation: *Aspergillus cristatus* SXHBTBU1934 was inoculated onto malt extract agar plates and cultured statically at 28 ℃~35 ℃ for 9 days to obtain a concentration of 1×10⁻⁶. 8 A CFU / mL suspension of *Aspergillus cristatus* SXHBTBU1934 spores was inoculated onto sterilized soybeans in 300 μL. The mixture was fermented at 31°C for 15 days, then freeze-dried at -80°C for 24 h, and finally pulverized to obtain fermented soybeans. (3) Separation and extraction: Weigh 1 g of fermented soybeans obtained in step (2), add 10 mL of methanol, and extract for 30 min with ultrasonic power of 500 W and frequency of 80 kHz. Centrifuge and pass through a membrane, then concentrate under reduced pressure at 45 ℃ to obtain crude extract. Dissolve the crude extract in 10 mL of mixed solution (dichloromethane:methanol volume ratio of 1:1), and separate using a Sephadex LH-20 gel column (3 cm × 60 cm). Each 30 mL fraction is taken as a fraction. Each fraction is transferred to a flask and concentrated under reduced pressure at 45 ℃ to obtain crude extract components F1, F2, F3, F4, F5, F6, F7, F8, and F9. Component F7 was separated by high performance liquid chromatography (HPLC) using a ZORBAX SB-C18 (Agilent) column with a particle size of 5 μm and dimensions of 9.4 × 250 mm. The mobile phase consisted of water and acetonitrile (A), with a gradient elution system of 5%–25% acetonitrile (0–30 min). The receiving retention time was 23.77 min. The sample was transferred to a flask and concentrated under reduced pressure at 45 °C to obtain the compound.
[0037] Example 2
[0038] The preparation steps for a phenolic acid compound (Aspeusoy acid A) are as follows: (1) Sterilization of raw materials: Weigh 8 g of soybeans into an Erlenmeyer flask, add 4 mL of distilled water, sterilize at 121 °C for 15 minutes to obtain sterilized soybeans; (2) Fermentation: *Aspergillus cristatus* SXHBTBU1934 was inoculated onto malt extract agar plates and cultured statically at 28 ℃~35 ℃ for 7 days to obtain a concentration of 1×10⁻⁶. 7 A CFU / mL suspension of *Aspergillus cristatus* SXHBTBU1934 spores was inoculated onto sterilized soybeans in 240 μL. The mixture was fermented at 28 °C for 17 days, then freeze-dried at -85 °C for 20 h, and finally pulverized to obtain fermented soybeans. (3) Separation and extraction: Take 1 g of fermented soybeans obtained in step (2), add 10 mL of methanol, and extract with ultrasonic power of 400 W and frequency of 90 kHz for 35 min. After centrifugation and membrane filtration, concentrate under reduced pressure at 45 ℃ to obtain crude extract. Dissolve crude extract in 10 mL of mixed solution (dichloromethane:methanol volume ratio of 1:2), and separate using a Sephadex LH-20 gel column (3 cm × 60 cm). Each 30 mL fraction is taken as a fraction. Each fraction is transferred to a flask and concentrated under reduced pressure at 45 ℃ to obtain crude extract components F1, F2, F3, F4, F5, F6, F7, F8, and F9. Component F7 was separated by high performance liquid chromatography (HPLC) using a ZORBAX SB-C18 (Agilent) column with a particle size of 5 μm and dimensions of 9.4 × 250 mm. The mobile phase consisted of water and acetonitrile, with a gradient elution system of 5%–25% acetonitrile (0–30 min). The receiving retention time was 23.77 min. The sample was transferred to a flask and concentrated under reduced pressure at 45 °C to obtain the compound.
[0039] Example 3
[0040] The preparation steps for a phenolic acid compound (Aspeusoy acid A) are as follows: (1) Sterilization of raw materials: Weigh 12 g of soybeans into an Erlenmeyer flask, add 6 mL of distilled water, sterilize at 121 °C for 15 minutes to obtain sterilized soybeans; (2) Fermentation: *Aspergillus cristatus* SXHBTBU1934 was inoculated onto malt extract agar plates and cultured statically at 28 ℃~35 ℃ for 10 days to obtain a concentration of 1×10⁻⁶. 9A CFU / mL suspension of *Aspergillus cristatus* SXHBTBU1934 spores was inoculated onto sterilized soybeans in 480 μL. The mixture was fermented at 35 °C for 13 days, then freeze-dried at -70 °C for 28 h, and finally pulverized to obtain fermented soybeans. (3) Separation and extraction: Weigh 1 g of fermented soybeans obtained in step (2), add 10 mL of methanol, and extract with ultrasonic power of 600 W and frequency of 60 kHz for 25 min. After centrifugation and membrane filtration, concentrate under reduced pressure at 45 ℃ to obtain crude extract. Dissolve crude extract in 10 mL of mixed solution (dichloromethane:methanol volume ratio of 2:1), and separate using a Sephadex LH-20 gel column (3 cm × 60 cm). Each 30 mL fraction is taken as a fraction. Each fraction is transferred to a flask and concentrated under reduced pressure at 45 ℃ to obtain crude extract components F1, F2, F3, F4, F5, F6, F7, F8, and F9. Component F7 was separated by high performance liquid chromatography (HPLC) using a ZORBAX SB-C18 (Agilent) column with a particle size of 5 μm and dimensions of 9.4 × 250 mm. The mobile phase consisted of water and acetonitrile (A), with a gradient elution system of 5%–25% acetonitrile (0–30 min). The receiving retention time was 23.77 min. The sample was transferred to a flask and concentrated under reduced pressure at 45 °C to obtain the compound.
[0041] Experimental Example 1: Structural Identification of Compounds
[0042] The structure of the compound obtained in Example 1 was identified using high-resolution mass spectrometry (HMR) and proton and carbon NMR spectra. HMR was performed using a Waters Xevo G3 QTof spectrometer, and proton and carbon NMR spectra were performed using a Bruker Avance IIIHD 500 NMR spectrometer. The mass spectrum of the target compound is shown below. Figure 1 As shown, the proton and carbon NMR spectra of the compounds are shown in Table 1. Figures 2-3 As shown.
[0043] Table 1. Signal assignment table for the proton and carbon NMR spectra of compounds.
[0044] Depend on Figure 1 It can be seen that the measured mass-to-charge ratio (m / z) of the molecular ion peak of the target compound is 353.0880. This ion is the [MH]- quasi-molecular ion formed by the removal of one proton from the compound. It is speculated that the molecular formula of the compound is C. 16 H 18 O9 has an unsaturation degree of 8.
[0045] From Table 1 and Figure 2It can be seen that the compound's 1H NMR spectrum contains one 1,2,3-trisubstituted benzene ring signal, 7.50 (H-2), 6.92 (H-5), 7.61 (H-6); one terminal double bond, 5.54 and 4.84 (H2-9); three methylene groups, 4.32 (H2-11), 1.93 (H2-12), 2.43 and 2.38 (H2-14); and one methyl group, 1.24 (H3-16).
[0046] From Table 1 and Figure 3 It can be seen that the compound's carbon NMR spectrum contains 16 signals, consistent with the aforementioned proton NMR signals: one 1,2,3-trisubstituted benzene ring signal (120.4 (C-1), 121.8 (C-2), 143.9 (C-3), 154.6 (C-4), 117.1 (C-5), 127.0 (C-6); one terminal double bond (153.9 (C-8) and 103.0 (C-9); three methylene groups (61.1 (C-11), 39.4 (C-12), 46.5 (C-14); one methyl group (27.4 (C-16)); and three carboxyl group signals (165.2 (C-7), 164.5 (C-10), 172.6 (C-15)). Based on the compound's molecular formula, the NMR signals identified the compound's structure as follows:
[0047] Formula 1, The compound was named Aspeusoy acid A.
[0048] Experimental Example 2: Antioxidant Activity Test of Compounds
[0049] Using the compound obtained in Example 1 as the test sample, six concentration gradients (1, 10, 20, 40, 80, 100 μg / mL) of the test sample solution and vitamin C control solution were prepared with dimethyl sulfoxide. (A) Determination of 1,1-diphenyl-2-trinitrophenylhydrazine radical (DPPH) scavenging ability Accurately weigh 19.7 mg of DPPH and dilute to 50 mL with anhydrous ethanol to prepare a 1.0 × 10⁻⁶ solution. -3 The DPPH stock solution was prepared at 0.2 mmol / L and stored at 4 ℃ in the dark. It was diluted to a working solution of 0.2 mmol / L immediately before use. The same batch of samples used the same stock solution and prepared fresh each time. Equal volumes of sample and DPPH solution were mixed and reacted in the dark for 30 min. The absorbance was measured at 517 nm. Three parallel experiments were conducted for each group. The clearance rate was calculated according to formula (1).
[0050] (1)
[0051] Where: A: Absorbance of the sample's ability to scavenge free radicals; A0: Absorbance of the sample solvent; A1: Initial absorbance of free radicals.
[0052] (B) Antioxidant activity assay using 2,2'-adiazono-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) method
[0053] Accurately weigh 0.0960 g of 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), add ultrapure water to a final volume of 25 mL, and prepare a 7 mmol / L stock solution; weigh 0.9461 g of potassium persulfate, add ultrapure water to a final volume of 25 mL, and prepare a potassium persulfate stock solution. Mix 5 mL of the ABTS stock solution with 88 μL of the potassium persulfate stock solution, and let stand at room temperature in the dark for 12–16 h to obtain the ABTS free radical stock solution; dilute with anhydrous ethanol before testing, and adjust the absorbance at 734 nm to 0.700 ± 0.020. Mix the ABTS free radical stock solution and the sample solution in equal volumes, let stand at room temperature in the dark for 6 min, and measure the absorbance at 734 nm. Set up 3 parallel groups for each group. Calculate the scavenging rate using the scavenging rate calculation formula (1).
[0054] The results show that the compound obtained in Example 1 of this invention has an IC50 scavenging capacity for DPPH free radicals. 50 The concentration was 25.49 μg / mL, indicating stronger antioxidant activity than vitamin C (33.2 μg / mL); the IC50 for scavenging ABTS free radicals was [not specified]. 50 The concentration was 34.17 μg / mL, and its antioxidant activity was comparable to that of vitamin C (32.22 μg / mL).
[0055] Experimental Example 3: Determination of Isoflavone Content in Fermented Soybeans
[0056] Taking the fermented soybeans obtained in step (2) of Example 1 as an example; Preparation of isoflavone standard curve: Accurately weigh 10 mg of standards (daidzein, genistein, daidzein, malonyl daidzein, acetylated daidzein, malonyl daidzein, daidzeinogen, acetylated daidzein, daidzein, genistein, and genistein), dissolve in methanol in a 10 mL volumetric flask, and dilute to the mark. Mix well to prepare a standard stock solution. Accurately pipette 1.0 mL of the standard stock solution into a 10 mL volumetric flask, dilute to the mark, and mix well to prepare a standard working solution. Use the standards to construct a standard curve. Perform chromatographic analysis on the standard working solution, with injection volumes of 0.5 μL, 1 μL, 2 μL, 3 μL, 4 μL, 5 μL, and 6 μL. Analyze using an Agilent high-performance liquid chromatography-mass spectrometry (HPLC-MS / MS) system. The chromatographic column is an XDB-C8 column with a particle size of 5 μm and dimensions of 4.6 × 150 mm. The mobile phase is 0.5% formic acid-acetonitrile solution and 0.5% formic acid aqueous solution.
[0057] Extraction of isoflavones from soybeans: 1 g each of raw soybeans and fermented soybeans obtained in step (2) of Example 1 were weighed, and 10 mL of methanol was added. Extraction was performed with ultrasonic assistance (ultrasonic frequency 80 kHz, power 500 W) for 30 min, followed by centrifugation and membrane filtration to obtain the sample to be tested. Analysis was performed using an Agilent high-performance liquid chromatography-mass spectrometry system. The results are shown in Table 2 and... Figure 4 As shown.
[0058] Table 2. Content of isoflavones in raw soybeans and fermented soybeans (mg / g)
[0059] From Table 2 and Figure 4The results showed that the total isoflavone content of soybeans before and after fermentation was 2.2182 mg / g before fermentation and 2.5636 mg / g after fermentation, an increase of 15.57%. Notably, the forms of isoflavones changed significantly: the total amount of glycoside isoflavones (daidzein, genistein, malonyl daidzein, and malonyl genistein) decreased from 2.2133 mg / g to 1.5540 mg / g, a decrease of 29.79%; while the total amount of aglycone isoflavones (daidzein, genistein, and genistein) increased dramatically from 0.0049 mg / g to 0.4725 mg / g, an increase of approximately 96.4 times. The glycoside:aglycone ratio of soybeans before and after fermentation was optimized from 451.7:1 to 4.4:1, with a significant increase in the proportion of aglycones. The content of daidzein increased from 0.0049 mg / g to 0.2072 mg / g (approximately 42.3 times the original amount). Genistein and daidzein, which were not detected in the raw material, reached 0.2481 mg / g and 0.0172 mg / g, respectively, after fermentation. In addition, the content of malonyl genistein decreased significantly from 0.9431 mg / g to 0.0976 mg / g, while acetylated genistein (0.3967 mg / g) and acetylated daidzein (0.14047 mg / g), which were not present in the raw material, were generated.
[0060] It can be seen that the content of daidzein in the fermented soybeans of this invention is 42.3 times that of the daidzein in unfermented soybeans, and the total daidzein content is 96.4 times that of unfermented soybeans. Compared with the prior art (Bioprocessing of soybeans...), this invention... Glycine max L.) by solid-state fermentation with Eurotium cristatum YL-1 improves total phenolic content, isoflavone aglycones, and antioxidant activity. (Yulian Chen et al., The Royal Society of Chemistry) In the solid-state fermentation method of soybeans using *Aspergillus cristatus* YL-1, the aglycone content of soybeans after fermentation is 10.4 times that before fermentation, and the total aglycone content is 9.4 times that before fermentation. The method provided by this invention significantly increases the isoflavone content in soybeans, especially the content of aglycone-type isoflavones.
[0061] The above results indicate that *Aspergillus cristatus* SXHBTBU1934 significantly increased the content of isoflavone aglycones during solid-state fermentation of soybeans. Since free isoflavone aglycones generally have a better free radical scavenging ability than glycosidic isoflavones, and aglycone isoflavones exhibit higher biological activity, the fermented soybeans prepared in this invention can efficiently achieve the bioconversion of isoflavones from glycosidic to aglycone forms, significantly improving the content and bioavailability of isoflavone aglycones.
[0062] Example 4: Quantitative Analysis of Secondary Metabolites of *Aspergillus cristatus* in Fermented Soybeans
[0063] Weigh 1 g of fermented soybeans obtained in step (2) of Example 1, add 10 mL of methanol, and extract with ultrasonic assistance for 30 min, then centrifuge and pass through a membrane. Analysis was performed using an Agilent high-performance liquid chromatography-mass spectrometry (HPLC-MS / MS) system. The chromatographic column was an Agilent Eclipse XDB-C8 with a particle size of 5 μm and a specification of 4.6 × 150 mm. A standard curve was constructed using standards to quantitatively analyze the secondary metabolites of *Aspergillus cristatus*. The mobile phase consisted of 0.5% formic acid-acetonitrile solution and 0.5% formic acid aqueous solution. The results are shown in Table 3.
[0064] Table 3 Summary of the content of secondary metabolites of *Eurotium cristatum* after fermentation of soybeans (content %)
[0065] Table 3 shows that the total content of secondary metabolites of *Aspergillus cristatus* after soybean fermentation was 1.290%. Among them, isodihydroaspergillus aureus (0.325%) was the highest, followed by tetrahydroaspergillus aureus (0.267%) and urchinin (0.224%). Eurocristatine exhibited hypoglycemic activity; variecolorin P significantly reduced lipid accumulation in HepG2 cells, demonstrating lipid-lowering activity; benzaldehyde derivatives such as dihydroaspergillus aureus, tetrahydroaspergillus aureus, and aspergillus aureus yellow pigment exhibited strong DPPH free radical scavenging activity. In summary, the *Aspergillus cristatus* SXHBTBU1934 fermentation system for soybeans in this invention not only generated a new compound (Aspeusoy acid A) with antioxidant activity but also improved the biotransformation and content of isoflavones; simultaneously, it accumulated various fungal secondary metabolites with antioxidant, hypoglycemic, and lipid-lowering biological activities. The fermented soybeans prepared by this invention have broad application prospects in the preparation of functional foods, health products and pharmaceutical functional additives with high antioxidant activity and high bioavailability.
[0066] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A phenolic acid compound, characterized in that, The structural formula of the compound is: Formula 1.
2. The method for preparing the compound according to claim 1, characterized in that, Includes the following steps: S1. Inoculate the spore suspension of *Aspergillus cristatus* SXHBTBU1934 into sterilized soybeans, ferment and culture, freeze dry, and pulverize to obtain fermented soybeans; S2. The fermented soybeans were extracted with methanol solvent under ultrasonic assistance for 25-35 min, centrifuged and filtered through a membrane, and concentrated under reduced pressure to obtain a crude extract. The ultrasonic extraction power is 400~600 W, and the frequency is 40~90 kHz; S3. Dissolve the crude extract in a mixed solution of dichloromethane and methanol in a volume ratio of (1~2):(1~2), and separate it using a Sephadex LH-20 gel column. Collect one fraction every 30 mL to obtain fractions 1 to 9. S4. The 7th fraction obtained in step S3 was separated by high performance liquid chromatography. The chromatographic column was a ZORBAX SB-C18 with a particle size of 5 μm and a specification of 9.4 × 250 mm. The mobile phase gradient elution system was 5%~25% acetonitrile, and the receiving retention time was 23.77 minutes to obtain the compound.
3. The preparation method according to claim 2, characterized in that, The ratio of the spore suspension of *Aspergillus cristatus* SXHBTBU1934 to soybeans in step S1 is 2-4 mL: 100 g.
4. The preparation method according to claim 2, characterized in that, The sterilized soybeans in step S1 also contain water, and the mass-to-volume ratio of the soybeans to the water is 8~12 g: 4~8 mL.
5. The preparation method according to claim 2, characterized in that, In step S1, the culture temperature for preparing the *Aspergillus cristatus* SXHBTBU1934 spore suspension is 28-35℃, and the culture time is 7-10 days.
6. The preparation method according to claim 2, characterized in that, The concentration of the spore suspension in step S1 is 1×10⁻⁶. 7 ~1×10 9 CFU / mL, and the accession number of the *Eurotium cristatum* SXHBTBU1934 is CGMCC NO. 21026.
7. The preparation method according to claim 2, characterized in that, The fermentation culture in step S1 is carried out at a temperature of 28℃~35℃ for 13~17 days.
8. The preparation method according to claim 2, characterized in that, The freeze-drying temperature in step S1 is -85 ℃ to -70 ℃, and the time is 20 to 28 h.
9. A fermented soybean, characterized in that, It includes the phenolic acid compounds as described in claim 1.
10. The use of a compound according to claim 1, a compound prepared by any one of claims 2 to 8, or fermented soybeans according to claim 9 in the preparation of functional formulations with antioxidant activity.
Citation Information
Patent Citations
Alkaloid compound and application thereof
CN115385900B
